%D8%A3%D9%84%D9%88%D8%AC%D9%84%D9%8A%D8%A8%D8%AA%D9%8A%D9%86Category:AlogliptinAlogliptin%CE%91%CE%BB%CE%BF%CE%B3%CE%BB%CE%B9%CF%80%CF%84%CE%AF%CE%BD%CE%B7AlogliptinAlogliptinaAlogliptineAlogliptin%E3%82%A2%E3%83%AD%E3%82%B0%E3%83%AA%E3%83%97%E3%83%81%E3%83%B3AlogliptinAlogliptinAlogliptinQ4734170%E9%98%BF%E6%A0%BC%E5%88%97%E6%B1%80
about
Long-term Study of Alogliptin as an Add-on to Rapid-Acting Insulin Secretagogues in Type 2 DiabetesAlogliptin/Pioglitazone (Liovel) Combination Tablets Survey on Long-term Use in Patients With Type 2 Diabetes MellitusAlogliptin Tablets Special Drug Use Surveillance Type 2 Diabetes Mellitus: Combination Therapy With BiguanidesAlogliptin Tablets Special Drug Use Surveillance: Mild Type 2 Diabetes MellitusAlogliptin Tablets Special Drug Use Surveillance Type 2 Diabetes Mellitus: Combination Therapy With SulfonylureaTreatment Preference for Weekly DPP-4 Inhibitors Versus Daily DPP-4 Inhibitors in Patients With Type 2 Diabetes MellitusStudy of Combination Therapy With SYR-322Effects of Alogliptin on Pancreatic Beta Cell FunctionEfficacy and Safety of Alogliptin Used Combination With Thiazolidine in Participants With Type 2 Diabetes in JapanA Study to Determine the Bioequivalence of Alogliptin and Pioglitazone When Administered as Individual Tablets and as Fixed-Dose Combination (FDC)-SYR-322-4833 BL Tablets to Healthy Russian ParticipantsA Study to Evaluate the Effect of add-on Pioglitazone or Glimepiride in Participants With Type 2 Diabetes Mellitus Inadequately Controlled by Alogliptin and Metformin TherapyEfficacy and Safety of Alogliptin vs. Acarbose in Chinese Type 2 Diabetes Mellitus (T2DM) Patients With High CV Risk or CHD Treated With Aspirin and Inadequately Controlled With Metformin Monotherapy or Drug NaiveAnti-inflammatory Status in DM2 Treated Patients
P4844
Efficacy and safety of alogliptin in Japanese patients with type 2 diabetes mellitus: a randomized, double-blind, dose-ranging comparison with placebo, followed by a long-term extension studyAlogliptin as an initial therapy in patients with newly diagnosed, drug naïve type 2 diabetes: a randomized, control trialPreclinical development of dipeptidyl peptidase IV inhibitor alogliptin: a brief overview.DPP-4 (CD26) inhibitor alogliptin inhibits atherosclerosis in diabetic apolipoprotein E-deficient mice.Natriuretic effect by exendin-4, but not the DPP-4 inhibitor alogliptin, is mediated via the GLP-1 receptor and preserved in obese type 2 diabetic mice.Alogliptin ameliorates postprandial lipemia and postprandial endothelial dysfunction in non-diabetic subjects: a preliminary report.Alogliptin for the treatment of type 2 diabetes.Alogliptin benzoate for the treatment of type 2 diabetes.An update in incretin-based therapy: a focus on dipeptidyl peptidase--4 inhibitors.Novel serine protease dipeptidyl peptidase IV inhibitor: alogliptin.Acute DPP-4 inhibition modulates vascular tone through GLP-1 independent pathwaysPharmacokinetics of alogliptin when administered with food, metformin, or cimetidine: a two-phase, crossover study in healthy subjects.Efficacy and safety of alogliptin added to metformin in Japanese patients with type 2 diabetes: a randomized, double-blind, placebo-controlled trial with an open-label, long-term extension study.The dipeptidyl peptidase-4 inhibitor alogliptin improves glycemic control in type 2 diabetic patients undergoing hemodialysis.Effect of additional administration of acarbose on blood glucose fluctuations and postprandial hyperglycemia in patients with type 2 diabetes mellitus under treatment with alogliptin.Quantitative model of the relationship between dipeptidyl peptidase-4 (DPP-4) inhibition and response: meta-analysis of alogliptin, saxagliptin, sitagliptin, and vildagliptin efficacy results.Lowering of postprandial lipids in individuals with type 2 diabetes treated with alogliptin and/or pioglitazone: a randomised double-blind placebo-controlled study.Efficacy and tolerability of the DPP-4 inhibitor alogliptin combined with pioglitazone, in metformin-treated patients with type 2 diabetes.Alogliptin plus voglibose in Japanese patients with type 2 diabetes: a randomized, double-blind, placebo-controlled trial with an open-label, long-term extension.Alogliptin as a third oral antidiabetic drug in patients with type 2 diabetes and inadequate glycaemic control on metformin and pioglitazone: a 52-week, randomized, double-blind, active-controlled, parallel-group study.Efficacy and safety of alogliptin added to pioglitazone in Japanese patients with type 2 diabetes: a randomized, double-blind, placebo-controlled trial with an open-label long-term extension study.Effects of chronic administration of alogliptin on the development of diabetes and β-cell function in high fat diet/streptozotocin diabetic mice.Immunohistochemistry for Anti-diabetes Drug, Alogliptin Using a Newly Prepared Monoclonal Antibody: Its Precise Localization in Rat Small Intestine[Alogliptin][A compounding agent of alogliptin and pioglitazone]
P921
Q61966082-D52F8B75-40DE-4889-A467-F216223D6540Q61970107-0C82D065-7AF5-45AE-9085-9A8D67C99704Q61975799-52CF166D-520A-4D25-A05A-285B46D40FCBQ61975800-F2E6EA78-5841-4CC5-A3DA-1B1E9BD1A067Q61975801-E72768F0-3E30-4538-A59B-8A0A94503250Q63012319-A8BB9C1B-C8C9-4ED7-8E32-82CAC2509EB6Q63319937-5B44070E-1064-4146-953C-F2F5AB14D09DQ63337248-3F1BC589-9530-47A2-831F-0C9275C263F8Q63337438-5706A6A9-0392-4A45-8461-E66B9CE7591FQ63399001-2FBE03BD-1237-4562-BA8A-81E370D38495Q63399503-17738DF8-8F23-421D-9E2E-EF3B6D5D6E39Q63593511-1CF87EC6-6FD0-4395-AC71-6E1A6C0605B7Q94934698-E77A7052-5E0E-48B1-ACCB-D99DEC01B49F
P4844
description
Medicamento
@es
chemesch Verbindung
@lb
chemical compound
@en
chemical compound
@en-ca
chemical compound
@en-gb
chemická sloučenina
@cs
chemická zlúčenina
@sk
chemiese verbinding
@af
chemische Verbindung
@de
chemische Verbindung
@de-ch
name
Alogliptin
@de
Alogliptin
@it
Alogliptin
@sh
Alogliptin
@sr
Alogliptin
@vi
alogliptica
@es
alogliptin
@en
alogliptine
@fr
Αλογλιπτίνη
@el
ألوجليبتين
@ar
type
label
Alogliptin
@de
Alogliptin
@it
Alogliptin
@sh
Alogliptin
@sr
Alogliptin
@vi
alogliptica
@es
alogliptin
@en
alogliptine
@fr
Αλογλιπτίνη
@el
ألوجليبتين
@ar
altLabel
Alogliptin
@en
Alogliptina
@en
Alogliptine
@en
Alogliptinum
@en
Nesina®
@en
SYR-322
@en
Vipidia
@el
Vipidia®
@en
prefLabel
Alogliptin
@de
Alogliptin
@it
Alogliptin
@sh
Alogliptin
@sr
Alogliptin
@vi
alogliptica
@es
alogliptin
@en
alogliptine
@fr
Αλογλιπτίνη
@el
ألوجليبتين
@ar